Active Monitoring for Ductal Carcinoma
Study Summary
This trial looks at whether active monitoring or surgery is better for low-risk DCIS. The hypothesis is that active monitoring does not lead to worse outcomes.
- Ductal Carcinoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
What criteria must be met for someone to qualify for participation in this experiment?
"Aspiring participants of this trial should have ductal carcinoma and be within the ages of 40-99. The protocol is accepting a maximum enrollment count of 1200 people."
To what extent is the participant roster of this study being populated?
"This clinical trial necessitates 1200 eligible patients. Allowing for multiple locations, individuals may join the study from New York-Presbyterian Weill Cornell Medical Center in NYC and Community Medical Center in Missoula, MT."
Are seniors being asked to be part of this experiment?
"This clinical study is in search of subjects aged between 40 and 99 years old."
Is this clinical investigation actively seeking new participants?
"Affirmative. Clinicaltrials.gov exhibits that this medical investigation is actively seeking volunteers, since it was established on February 22nd 2017 and last updated September 19th 2022. The trial necessitates 1200 individuals to be accepted at 100 individual centres."
How many facilities are currently hosting this experiment?
"This clinical trial is running out of New York-Presbyterian Weill Cornell Medical Center in Manhattan, Community Medical Center in Missoula, Montana, Saint Joseph Hospital- Cancer Centers of Colorado in Lafayette, Colorado and a hundred other medical sites."